by Christine Taxin
June 24th, 2019
The mouth is, was, and forever will be part of the body. The old model in
In order to get to the basis of inflammation, which is a key driver of metabolic syndrome, one must address all sources of inflammation in the body. The most common site of inflammation, the most easily observed, and importantly the easiest to treat, is periodontal inflammation. Periodontal disease is not a local disease, as it is often treated. For instance, evidence suggests that “periodontal changes are the first clinical manifestation of diabetes,” and “evidence indicates that periodontitis is a significant risk factor for poor glycemic control” (these quotes are from Relationship Between Oral Health and Diabetes Mellitus, October 2008, Lamster Et al.). In clinical practice, we are guilty of overlooking a host of other oral signs of diabetes beyond gingival/periodontal changes, such as salivary dysfunction, candidiasis, taste interference, neurosensory disorders, and oral infections. Enamel changes are often the first clinical manifestation of silent reflux.
Periodontal pathogens and the subsequent inflammatory mediators go
As AAOSH team members, we have heard and read evidenced-based research from scientists studying infertility and pre-term birth, heart attack and stroke prevention, cognitive decline and Alzheimer’s disease prevention, cancer prevention, metabolic syndrome prevention and more. Every scientist has shown data that if we don’t treat underlying inflammation, we will not have long term successful outcomes of systemic disease.
This is a profound time in healthcare reform and it’s important not only to get informed on the latest knowledge and facts regarding